Search

everythinglearnresearchcommunity

for

Search:↓

Hormone treatment for transgender patients may not need to be stopped before surgery, but more research is needed, especially on estrogen.

Gynecologists should provide comprehensive care for transgender patients, including mental health evaluation, hormone therapy, and surgical options, while monitoring for side effects and ensuring patient safety.

Hormone treatments for transgender individuals generally improve mental health and physical transition, with some health risks that require medical supervision.

Chemotherapy caused a woman's permanent hair loss and early menopause.

A certain gene variant may increase the risk of polycystic ovary syndrome in Chinese women.

Men with frontal male pattern baldness may have a higher risk of gastric cancer.

The treatment reduced hair growth and testosterone in women with excess hair and had some effects on stress responses.

Kidney stones and hair loss are significantly related in people under 60 years old.

Long-term use of finasteride in women can cause hormonal changes, DNA damage, and menstrual issues.

Barn owls with smaller black spots have higher testosterone levels, which might be due to genetic effects on hormone regulation rather than hormone effects on coloration.

Genes and hormones cause hair loss, with four genes contributing equally.

Women have unique stroke risks due to hormones, contraceptives, pregnancy, and menopause.

Women with idiopathic hirsutism and PCOS have higher RBP4 levels, and PCOS is linked to greater insulin resistance; weight management may help both conditions.

The document concludes that future heart disease research should account for sex-specific differences to improve diagnosis, treatment, and outcomes.

Over half of the adult women with acne in the study had higher than normal levels of male hormones, especially DHEA.

Hormone therapies like birth control pills and spironolactone are safe and effective for treating women's adult acne.

Men with balding at age 45 had higher IGF-1 and lower IGFBP-3, suggesting these factors might be important in male pattern baldness.

Men with balding at age 45 had higher IGF-1 and lower IGFBP-3 levels, suggesting these factors might influence male pattern baldness.

The treatment effectively reduced hair growth and was safe for patients with PCOS, but it needs better bleeding control.

Acne severity in women with PCOS is linked to younger age, lower body weight, and more body hair, but not to hormone levels.

Polycystic Ovary Syndrome likely starts in childhood and may be genetic and influenced by early hormone exposure.

Menopause and aging can affect women's quality of life and sexuality, but hormone therapies may help alleviate these issues.

Certain hormone treatments can improve acne and related conditions in women.

Different types of PCOS in Chinese Han women show varying levels of male hormone and metabolic issues.

The study found no significant difference in stress hormone levels between people with alopecia areata and healthy individuals, suggesting that the disease is not caused by an overactive stress response system.

Men with male pattern baldness may not have different hormone levels, but their hair follicles are likely more sensitive to hormones.

Testosterone's role in women's sex drive is unclear and needs more research, as low levels don't always mean less sexual interest and high levels can cause side effects.

Premature ovarian insufficiency (POI) can harm women's sexual health, and they may benefit from hormone therapy and counseling.

DHEA may help with sexual function when used intravaginally by menopausal women but is similar to hormone therapy in other aspects and might cause more side effects like acne and hair loss.

Longer anogenital distance may indicate a higher chance of having polycystic ovary syndrome, and measuring this distance along with hormone levels could improve diagnosis.